Clinical significance of whole body thallium-201 chloride scintigraphy in multiple myeloma

Kakuigaku

Volumn 33, Issue 1, 1996, Pages 33-47

  Tsubuku, Masahiko ^a  

^a TOHO UNIVERSITY   (Japan)

Author keywords

201Tl chloride; Bone marrow; Multiple myeloma; Tumor burden; Whole body scanning

Indexed keywords

THALLIUM CHLORIDE TL 201;

ARTICLE; CANCER STAGING; CHLORIDE TRANSPORT; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DRUG BLOOD LEVEL; HUMAN; MULTIPLE MYELOMA; NUCLEAR MAGNETIC RESONANCE IMAGING;

AGED; AGED, 80 AND OVER; BONE AND BONES; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; THALLIUM; THALLIUM RADIOISOTOPES; WHOLE-BODY COUNTING;

EID: 0030029641     PISSN: 00227854     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bartl R, Frisch B, Fateh-Moghadam A, Kettner G, Jager K, Sommerfeld W: Histological classification and staging of multiple myeloma. Retrospective and prospective study of 674 cases. Amer J Clin Pathol 87: 342-355, 1987
2. Greenfield GB: Radiology of bone disease, 4th ed., J.B. Lippincott Company, Philadelphia, 1986, p. 446
3. Edeiken J: Edeiken's Roentgen Diagnosis of disease of bone. 4th ed., Williams &Wilkins, Baltimore, 1990, p. 436
4. Woolfenden JM, Pitt MJ, Durie BGM, Moon TE: Comparison of bone scintigraphy and radiography in multiple myeloma. Radiology 134: 723-728, 1980
5. Bataille R, Chevalier JC, Rossi M, Sany J: Bone scintigraphy in plasma-cell myeloma. Radiology 145: 801-804, 1982
6. Ludwig H, Kumpan W, Sinzinger H: Radiography and bone scintigraphy in multiple myeloma: a comparative analysis. Br J Radiol 55: 173-181, 1982
7. Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G: Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetiumMDP in evaluation of chemotherapy response. J Nucl Med 31: 567-572, 1990
8. Durie BGM, Salmon SE: A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36: 842-854, 1975
9. Alexanian R: Diagnosis and management of multiple myeloma. Wiernik PH, Canellous GP, Kyle RA, Schifter CA, eds. Neoplastic diseases of the blood. Churchill Livingstone, New York, 1985, p. 541
10. Bataille R, Durie BGM, Grenier J: Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging. Br J Haematology 55: 439-447, 1983
11. Garewal H, Dune BGM, Kyle RA, Finley P, Bower B, Serokman R: Serum beta2-microglobulin in the initial staging and subsequent monitoring of monoclonal plasma cell disorders. J Clin Oncol 2: 51-57, 1984
12. Rahmouni A, Divine M, Mathieu D, Golli M, Dao TH, Jazaerli N, et al: Detection of multiple myeloma involving the spine: Efficacy of fat-suppression and Contrast-enhanced MR imaging. AJR 160: 1049-1052, 1993
13. Kyle RA: Multiple myeloma review of 869 cases. Mayo Clin Proc 50: 29-40, 1975
14. Solomon A, Rahamani R, Seligsohn U, Ben-Artzi F: Multiple myeloma: Early vertebral involvement assessed by computerised tomography. Skeletal Radiol 11: 258-261, 1984
15. Fruhwald F, Tscholakoff D, Schwaighofer B, Wicke L, Neuhold A, Ludwig H: Magnetic resonance imaging of the lower vertebral column in patients with multiple myeloma. Invest Radiol 23: 193-199, 1988
16. Elligsen JD, Thompson JE, Frey HE, Kruuv J: Correlation of (Na-K)-ATPase activity with growth of normal and transformed cells. Exp Cell Res 87: 233-240, 1974
17. Bradley-Moore PR, Lebowitz E, Green MW, Atkins HL, Ansari AN: Thallium-201 for medical use II: Biological behavior. J Nucl Med 16: 156-160, 1975
18. Laurin S, Akerman M, Kindblom LG, Gunterberg B: Angiography in myeloma (plasmacytoma). Skeletal Radiol 4: 8-18, 1979
19. Cavailoles F, Vitaux F, Petiet AI: Thallium uptake in fasted and nonfasted rats. Eur J Nucl Med 8: 87-88, 1983
20. Mundy GR, Raisz LG, Cooper RA, Schechter GP, Salmon SE: Evidence for the secretion of an osteoclast stimulating factor in multiple myeloma. N EngI J Med 291: 1041-1046, 1974
21. Bataille R, Chappard D, Klein B: Mechanisms of bone lesions in multiple myeloma. Hematology/Oncology Clinics of North America 6: 285-295, 1992
22. Leonard RCF, Owen JP, Proctor SJ, Hamilton PJ: Multiple myeloma: Radiology or bone scanning? Clin Radiol 32: 291-295, 1981
23. Atkins HL, Budinger TF, Lebowitz E, Ansari AN, Greene W, Fairchild RG, et al: Thallium-201 for medical use. part 3: human distribution and physical imaging properties. J Nucl Med 18: 133-140, 1977
24. Abdel-Dayem HM, Sanchez J, Al-Mohannadi S, Kempf J: Diffuse thallium-201-chloride uptake in hypermetabolic bone marrow following treatment with granulocyte stimulating factor. J Nucl Med 33: 2014-2016, 1992
25. Sayman HB, Sonmezoglu K, Altiok E, Devranoglu G, Ferhanoglu B: Unexpected bone marrow uptake of thallium-201 in nonsecretory myeloma. J Nucl Med 36: 250-251,1995
26. Woodard HQ, Holodny E: A summary of the data of Mechanik on the distribution of human bone marrow. Physics in Med and Biol 5: 57-59, 1960
27. Ellis RE: The distribution of active bone marrow in the adult. Physics in Med and Biol 5: 255-258, 1961
28. Kelly KA, Durie B, Maclennan IC: Prognostic factors and staging systems for multiple myeloma: comparisons between the medical research council studies in the United Kingdom and the southwest oncology group studies in the United States. Hematol Oncol 6: 131-140,1988
29. Sezaki T, Izumi K, Hoshijima T, Adachi T, Takahashi I, Kimura I : Tumor distribution classification system for multiple myeloma: Clinical features and prognosis. Acta Haemal Jpn 49: 1784-1791,1986